Anti-fibrotic effect of isorhamnetin and its derivatives on disruption of pancreatic ductal adenocarcinoma desmoplasia by regulation of cancer-associated fibroblasts

• Project/Area Number: 21K14789
• Research Category: Grant-in-Aid for Early-Career Scientists
• Allocation Type: Multi-year Fund
• Review Section: Basic Section 38030:Applied biochemistry-related
• Research Institution: National Institute of Advanced Industrial Science and Technology
• Principal Investigator: Ganbold Munkhzul 国立研究開発法人産業技術総合研究所, その他部局等, 研究員 (00882169)
• Project Period (FY): 2021-04-01 – 2024-03-31
• Project Status: Adopted (Fiscal Year 2021)
• Budget Amount: ¥4,420,000 (Direct Cost: ¥3,400,000、Indirect Cost: ¥1,020,000); Fiscal Year 2023: ¥650,000 (Direct Cost: ¥500,000、Indirect Cost: ¥150,000); Fiscal Year 2022: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000); Fiscal Year 2021: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)